GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (STU:OLY1) » Definitions » Cyclically Adjusted PS Ratio

Olympus (STU:OLY1) Cyclically Adjusted PS Ratio : 3.85 (As of May. 25, 2024)


View and export this data going back to . Start your Free Trial

What is Olympus Cyclically Adjusted PS Ratio?

As of today (2024-05-25), Olympus's current share price is €14.815. Olympus's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €3.85. Olympus's Cyclically Adjusted PS Ratio for today is 3.85.

The historical rank and industry rank for Olympus's Cyclically Adjusted PS Ratio or its related term are showing as below:

STU:OLY1' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.12   Med: 2.65   Max: 5.19
Current: 3.95

During the past years, Olympus's highest Cyclically Adjusted PS Ratio was 5.19. The lowest was 1.12. And the median was 2.65.

STU:OLY1's Cyclically Adjusted PS Ratio is ranked worse than
64.69% of 473 companies
in the Medical Devices & Instruments industry
Industry Median: 2.17 vs STU:OLY1: 3.95

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Olympus's adjusted revenue per share data for the three months ended in Mar. 2024 was €1.363. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €3.85 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Olympus Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Olympus's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olympus Cyclically Adjusted PS Ratio Chart

Olympus Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.43 3.73 3.91 3.78 3.42

Olympus Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.78 3.66 3.08 3.19 3.42

Competitive Comparison of Olympus's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Olympus's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Olympus's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Olympus's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Olympus's Cyclically Adjusted PS Ratio falls into.



Olympus Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Olympus's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=14.815/3.85
=3.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olympus's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Olympus's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.363/107.2000*107.2000
=1.363

Current CPI (Mar. 2024) = 107.2000.

Olympus Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.880 98.000 0.963
201409 0.992 98.500 1.080
201412 0.968 97.900 1.060
201503 1.203 97.900 1.317
201506 0.986 98.400 1.074
201509 1.127 98.500 1.227
201512 1.085 98.100 1.186
201603 1.231 97.900 1.348
201606 1.040 98.100 1.136
201609 1.151 98.000 1.259
201612 1.092 98.400 1.190
201703 1.262 98.100 1.379
201706 1.007 98.500 1.096
201709 1.093 98.800 1.186
201712 1.107 99.400 1.194
201803 1.200 99.200 1.297
201806 1.028 99.200 1.111
201809 1.126 99.900 1.208
201812 1.142 99.700 1.228
201903 1.240 99.700 1.333
201906 1.090 99.800 1.171
201909 1.264 100.100 1.354
201912 1.237 100.500 1.319
202003 1.267 100.300 1.354
202006 0.877 99.900 0.941
202009 1.124 99.900 1.206
202012 1.213 99.300 1.310
202103 1.303 99.900 1.398
202106 1.122 99.500 1.209
202109 1.159 100.100 1.241
202112 1.131 100.100 1.211
202203 1.218 101.100 1.291
202206 1.066 101.800 1.123
202209 1.243 103.100 1.292
202212 1.237 104.100 1.274
202303 1.338 104.400 1.374
202306 1.080 105.200 1.101
202309 1.174 106.200 1.185
202312 1.272 106.800 1.277
202403 1.363 107.200 1.363

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Olympus  (STU:OLY1) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Olympus Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Olympus's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Olympus (STU:OLY1) Business Description

Traded in Other Exchanges
Address
Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914
Olympus Corp manufactures and sells precision instruments for the healthcare industry. The firm operates in three segments: scientific solutions, imaging, and medical. The scientific solutions segment sells microscopes and other imaging tools to life sciences and industrial customers. The imaging segment sells digital cameras under the Olympus brand. The medical segment supplies medical equipment, including gastrointestinal and surgical endoscopes and endotherapy devices. This segment generates the vast majority of revenue. Sales in Asia and North America contribute the largest proportions of revenue.

Olympus (STU:OLY1) Headlines

No Headlines